{
    "id": "b7e57ea4-d985-4167-8c2d-716cf3c60114",
    "indications": {
        "text": "gabapentin capsules indicated : management postherpetic neuralgia adults adjunctive therapy treatment partial onset seizures , without secondary generalization , adults pediatric patients 3 years older epilepsy",
        "doid_entities": [
            {
                "text": "epilepsy (DOID:1826)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1826"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "postherpetic neuralgia ( 2.1 ) dose titrated needed dose 1,800 mg/day day 1 : single 300 mg dose day 2 : 600 mg/day ( i.e . , 300 mg two times day ) day 3 : 900 mg/day ( i.e . , 300 mg three times day ) epilepsy partial onset seizures ( 2.2 ) patients 12 years age older : starting dose 300 mg three times daily ; may titrated 600 mg three times daily patients 3 11 years age : starting dose range 10 15 mg/kg/day , given three divided doses ; recommended dose patients 3 4 years age 40 mg/kg/day , given three divided doses ; recommended dose patients 5 11 years age 25 35 mg/kg/day , given three divided doses . recommended dose reached upward titration period approximately 3 days dose adjusted patients reduced renal function ( 2.3 , 2.4 )",
        "doid_entities": [
            {
                "text": "epilepsy (DOID:1826)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1826"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "gabapentin capsules , usp available containing 100 mg , 300 mg 400 mg gabapentin , usp , supplied follows : 100 mg capsules : size ' 3 ' hard gelatin capsules white opaque cap white opaque body , imprinted `` 100 mg `` blue ink cap `` 236 `` blue ink body , filled white off-white powder . capsules supplied bottles : bottles 30 capsules child-resistant closure ndc 16571-867-03 bottles 100 capsules child-resistant closure ndc 16571-867-01 bottles 500 capsules ndc 16571-867-50 bottles 1,000 capsules ndc 16571-867-10 300 mg capsules : size ' 1 ' hard gelatin capsules yellow opaque cap yellow opaque body , imprinted `` 300 mg `` blue ink cap `` 235 `` blue ink body , filled white off-white powder . capsules supplied bottles : bottles 30 capsules child-resistant closure ndc 16571-868-03 bottles 100 capsules child-resistant closure ndc 16571-868-01 bottles 500 capsules ndc 16571-868-50 bottles 1,000 capsules ndc 16571-868-10 400 mg capsules : size ' 0 ' hard gelatin capsules orange opaque cap orange opaque body , imprinted `` 400 mg `` blue ink cap `` 234 `` blue ink body , filled white off-white powder . capsules supplied bottles : bottles 30 capsules child-resistant closure ndc 16571-869-03 bottles 100 capsules child-resistant closure ndc 16571-869-01 bottles 500 capsules ndc 16571-869-50 bottles 1,000 capsules ndc 16571-869-10 storage store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; [ usp controlled room temperature ] .",
    "adverseReactions": "gabapentin capsules contraindicated patients demonstrated hypersensitivity ingredients .",
    "ingredients": [
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_42797"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "FD&C BLUE NO. 1 ALUMINUM LAKE",
            "code": "J9EQA3S2JM"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        }
    ],
    "organization": "Rising Pharma Holdings, Inc.",
    "name": "gabapentin",
    "effectiveTime": "20250125",
    "indications_original": "Gabapentin Capsules are indicated for: \n                  \n                     Management      of postherpetic neuralgia in adults\n                     Adjunctive      therapy in the treatment of partial onset seizures, with and without      secondary generalization, in adults and pediatric patients 3 years and      older with epilepsy",
    "contraindications_original": "Postherpetic      Neuralgia ( 2.1 ) Dose      can be titrated up as needed to a\u00a0\u00a0\u00a0\u00a0\u00a0 dose of 1,800 mg/day Day      1: Single 300 mg dose Day      2: 600 mg/day (i.e., 300 mg two times\u00a0\u00a0\u00a0\u00a0\u00a0 a day) Day      3: 900 mg/day (i.e., 300 mg three\u00a0\u00a0\u00a0\u00a0\u00a0 times a day) Epilepsy      with Partial Onset Seizures ( 2.2 ) Patients      12 years of age and older:\u00a0\u00a0\u00a0\u00a0\u00a0 starting dose is 300 mg three times daily;      may be titrated up to 600 mg\u00a0\u00a0\u00a0\u00a0\u00a0 three times daily Patients      3 to 11 years of age: starting\u00a0\u00a0\u00a0\u00a0\u00a0 dose range is 10 to 15 mg/kg/day,      given in three divided doses;\u00a0\u00a0\u00a0\u00a0\u00a0 recommended dose in patients 3 to 4      years of age is 40 mg/kg/day, given in\u00a0\u00a0\u00a0\u00a0\u00a0 three divided doses; the      recommended dose in patients 5 to 11 years of age\u00a0\u00a0\u00a0\u00a0\u00a0 is 25 to 35 mg/kg/day,      given in three divided doses. The recommended dose\u00a0\u00a0\u00a0\u00a0\u00a0 is reached by      upward titration over a period of approximately 3 days Dose      should be adjusted in patients with\u00a0\u00a0\u00a0\u00a0\u00a0 reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions_original": "Gabapentin Capsules, USP are available containing 100 mg, 300 mg or 400 mg of gabapentin, USP, supplied as follows:\n                  100 mg capsules:\n                  Size '3' Hard gelatin capsules with white opaque cap and white opaque body, imprinted \"100 mg\" in blue ink on cap and \"236\" in blue ink on body, filled with white to off-white powder.\n                  Capsules are supplied in bottles of:\n                  Bottles of 30 Capsules with child-resistant closure \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 16571-867-03\n                  Bottles of 100 Capsules with child-resistant closure \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 16571-867-01\n                  Bottles of 500 Capsules \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 16571-867-50\n                  Bottles of 1,000 Capsules \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 16571-867-10\n                  \u00a0\u00a0\u00a0\u00a0\n                  300 mg capsules:\n                  Size '1' Hard gelatin capsules with yellow opaque cap and yellow opaque body, imprinted \"300 mg\" in blue ink on cap and \"235\" in blue ink on body, filled with white to off-white powder.\n                  Capsules are supplied in bottles of:\n                  Bottles of 30 Capsules with child-resistant closure \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 16571-868-03\n                  Bottles of 100 Capsules with child-resistant closure \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 16571-868-01\n                  Bottles of 500 Capsules \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 16571-868-50\n                  Bottles of 1,000 Capsules \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 16571-868-10\n                  400 mg capsules:\n                  Size '0' Hard gelatin capsules with orange opaque cap and orange opaque body, imprinted \"400 mg\" in blue ink on cap and \"234\" in blue ink on body, filled with white to off-white powder.\n                  Capsules are supplied in bottles of:\n                  Bottles of 30 Capsules with child-resistant closure \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 16571-869-03\n                  Bottles of 100 Capsules with child-resistant closure \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 16571-869-01\n                  Bottles of 500 Capsules \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 16571-869-50\n                  Bottles of 1,000 Capsules \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 16571-869-10\n                  \n                     Storage\n                  \n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Gabapentin capsules are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients.",
    "drug": [
        {
            "name": "gabapentin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_42797"
        }
    ]
}